20 April 2022 : The Annual General Meeting ofAker BioMarine ASA was held today as a digital meeting with online participation. All proposals on the agenda were adopted, cf. Notice of Annual General Meeting attached to the stock exchange release dated29 March 2022 . The complete minutes are attached to this release. For further information, please contactCarl Christian Bachke , Investor Relations Mobile: +47 909 808 48 Email: carl.bachke@akerbiomarine.com This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act. AboutAker BioMarine Aker BioMarine is a leading biotech innovator and Antarctic krill-harvesting company developing krill-derived products for pharma, consumer health and wellness as well as animal nutrition. The company has a strong position in its industry and is the world's leading supplier of krill, the natural, powerful and health promoting source of nutrients from the pristine waters ofAntarctica .Aker BioMarine is listed onOslo Stock Exchange (AKBM). More information is available at www.akerbiomarine.com.
Click here for more information
© Oslo Bors ASA, source